10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
AMGEN INC | |||
Ticker: AMGN Fiscal Year: 2011 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2011 10-K (Filed: Feb 29, 2012) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2011 | Dec 31, 2010 | Dec 31, 2009 | |
| Cash flows from operating activities: | |||
| Net income | $ 3,683 | 4,627 | 4,605 |
| Depreciation and amortization | 1,060 | 1,017 | 1,049 |
| Stock-based compensation expense | 341 | 353 | 284 |
| Deferred income taxes | (399) | (167) | 47 |
| Property, plant and equipment impairments | 6 | 118 | 21 |
| Dividend received from equity investee | 0 | 0 | 110 |
| Other items, net | 63 | 140 | 111 |
| Changes in operating assets and liabilities, net of acquisitions: | |||
| Trade receivables, net | (557) | (210) | (36) |
| Inventories | (383) | 153 | (134) |
| Other assets | (133) | 36 | (3) |
| Accounts payable | (95) | 142 | 71 |
| Accrued income taxes | (20) | (656) | (142) |
| Legal reserve | 780 | 0 | 0 |
| Other liabilities | 773 | 234 | 353 |
| Net cash provided by operating activities | 5,119 | 5,787 | 6,336 |
| Cash flows from investing activities: | |||
| Purchases of property, plant and equipment | (567) | (580) | (530) |
| Cash paid for acquisitions, net of cash acquired | (701) | 0 | 0 |
| Purchases of marketable securities | (21,183) | (14,602) | (12,418) |
| Proceeds from sales of marketable securities | 20,871 | 10,485 | 8,252 |
| Proceeds from maturities of marketable securities | 749 | 642 | 1,443 |
| Other | 45 | (97) | 51 |
| Net cash used in investing activities | (786) | (4,152) | (3,202) |
| Cash flows from financing activities: | |||
| Repurchases of common stock | (8,315) | (3,786) | (3,208) |
| Repayment of debt | (2,500) | 0 | (1,000) |
| Repayments of commercial paper | (762) | 0 | 0 |
| Dividends paid | (500) | 0 | 0 |
| Net proceeds from issuance of debt | 10,387 | 2,471 | 1,980 |
| Net proceeds from issuance of commercial paper | 762 | 0 | 0 |
| Other | 254 | 83 | 204 |
| Net cash used in financing activities | (674) | (1,232) | (2,024) |
| Increase in cash and cash equivalents | 3,659 | 403 | 1,110 |
| Cash and cash equivalents at beginning of period | 3,287 | 2,884 | |
| Cash and cash equivalents at end of period | 6,946 | 3,287 | 2,884 |
| External Links | |
| AMGEN INC (AMGN) Fiscal Year 2011 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |